Israel Chemicals Ltd (ICL) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in Israel Chemicals Ltd (NYSE:ICL) by 5.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,963,515 shares of the basic materials company’s stock after selling 121,385 shares during the period. Bank of New York Mellon Corp owned about 0.15% of Israel Chemicals worth $8,959,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. BlackRock Inc. increased its holdings in shares of Israel Chemicals by 13.9% in the 1st quarter. BlackRock Inc. now owns 113,993 shares of the basic materials company’s stock worth $483,000 after buying an additional 13,942 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of Israel Chemicals by 1.8% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 904,380 shares of the basic materials company’s stock worth $3,812,000 after buying an additional 15,831 shares during the last quarter. Aperio Group LLC increased its holdings in shares of Israel Chemicals by 13.6% in the 1st quarter. Aperio Group LLC now owns 206,096 shares of the basic materials company’s stock worth $874,000 after buying an additional 24,725 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Israel Chemicals by 29.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 144,534 shares of the basic materials company’s stock worth $659,000 after buying an additional 33,274 shares during the last quarter. Finally, Stifel Financial Corp increased its holdings in shares of Israel Chemicals by 276.8% in the 1st quarter. Stifel Financial Corp now owns 45,338 shares of the basic materials company’s stock worth $185,000 after buying an additional 33,305 shares during the last quarter. 8.11% of the stock is currently owned by hedge funds and other institutional investors.

ICL stock opened at $6.18 on Thursday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.76 and a current ratio of 1.35. Israel Chemicals Ltd has a 52 week low of $3.85 and a 52 week high of $6.30. The firm has a market cap of $8.05 billion, a P/E ratio of 19.94 and a beta of 1.15.

Israel Chemicals (NYSE:ICL) last released its earnings results on Wednesday, August 1st. The basic materials company reported $0.09 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.08 by $0.01. Israel Chemicals had a net margin of 22.74% and a return on equity of 14.16%. The company had revenue of $1.37 billion for the quarter. During the same period in the prior year, the business posted $0.05 EPS. Israel Chemicals’s revenue for the quarter was up 3.7% on a year-over-year basis. research analysts expect that Israel Chemicals Ltd will post 0.36 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 4th. Investors of record on Tuesday, August 21st were issued a dividend of $0.043 per share. The ex-dividend date of this dividend was Monday, August 20th. This represents a $0.17 annualized dividend and a dividend yield of 2.78%. This is a positive change from Israel Chemicals’s previous quarterly dividend of $0.04. Israel Chemicals’s dividend payout ratio (DPR) is currently 32.26%.

ICL has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of Israel Chemicals from a “sell” rating to a “hold” rating in a report on Wednesday, August 29th. BMO Capital Markets reissued a “hold” rating and issued a $5.25 price target on shares of Israel Chemicals in a report on Wednesday, September 19th. Finally, ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a report on Friday, August 24th. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $5.25.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Featured Article: How to Invest in an Index Fund

Institutional Ownership by Quarter for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply